DOI QR코드

DOI QR Code

Ectopic Overexpression of Coiled-Coil Domain Containing 110 Delays G2/M Entry in U2-OS Cells

  • Lee, Sue Nyoung (Dept. of Nanobiomedical Science & BK21 PLUS Research Center for Regenerative Medicine, Dankook University) ;
  • Hong, Kyeong-Man (Research Institute, National Cancer Center) ;
  • Seong, Yeon Sun (Dept. of Nanobiomedical Science & BK21 PLUS Research Center for Regenerative Medicine, Dankook University) ;
  • Kwak, Sahng-June (Dept. of Biochemistry, College of Medicine, Dankook University)
  • 투고 : 2020.04.27
  • 심사 : 2020.05.19
  • 발행 : 2020.06.30

초록

Coiled-coil domain containing 110 (CCDC110, KM-HN-1) is a protein containing C-terminal coiled-coil domain (CCD) which was previously discovered as a member of the human cancer/testis antigen (CTA). In addition, CCDC110 has both nuclear localization signal sequence and the leucine zipper motif. Although the functional role of CCDC110 has yet to be fully identified, the mRNA expression levels of CCDC110 are known to be highly elevated in various cancer types including testis, implying its relevance to cancer pathogenesis. In this study, we first developed several monoclonal antibody (mAb) hybridoma clones targeting CCDC110 and further isolated clone by characterizing for its specificity using immunoblotting and immunoprecipitation approaches with basal parenchymal sperm cells in testis tissue. Next, using these mAbs, we showed that the Tet-inducible overexpression of CCDC110 protein delayed the entry of G2/M phase in U2-OS osteosarcoma cells. Based on these results, we propose that CCDC110 plays a crucial role in cell cycle progression.

키워드

참고문헌

  1. Boulikas T (1993) Nuclear localization signals (NLS). Crit Rev Eukaryot Gene Expr 3:193-227.
  2. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94:1914-1918. https://doi.org/10.1073/pnas.94.5.1914
  3. Cobbe N, Heck MMS (2000) Review: SMCs in the world of chromosome biology- from prokaryotes to higher eukaryotes. J Struct Biol 129:123-143. https://doi.org/10.1006/jsbi.2000.4255
  4. Condomines M, Hose D, Raynaud P, Hundemer M, De Vos J, Baudard M, Moehler T, Pantesco V, Moos M, Schved JF, Rossi JF, Reme T, Goldschmidt H, Klein B (2007) Cancer/testis genes in multiple myeloma: Expression patterns and prognosis value determined by microarray analysis. J Immunol 178:3307-3315. https://doi.org/10.4049/jimmunol.178.5.3307
  5. Harlow E, Lane D (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, NY.
  6. Hoshino I, Nagata M, Takiguchi N, Nabeya Y, Ikeda A, Yokoi S, Kuwajima A, Tagawa M, Matsushita K, Satoshi Y, Hideaki S (2017) Panel of autoantibodies against multiple tumorassociated antigens for detecting gastric cancer. Cancer Sci 108:308-315. https://doi.org/10.1111/cas.13158
  7. Landschulz WH, Johnson PF, McKnight SL (1988) The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 240:1759-1764. https://doi.org/10.1126/science.3289117
  8. Lee KH (2012) Ectopic expression of cenexin1 S796A mutant in ODF2+/- knockout background causes a sperm tail development defect. Dev Reprod 16:363-370. https://doi.org/10.12717/DR.2012.16.4.363
  9. Lucerna M, Pomyje J, Mechtcheriakova D, Kadl A, Gruber F, Bilban M, Sobanov Y, Schabbauer G, Breuss J, Wagner O, Bischoff M, Clauss M, Binder BR, Hofer E (2006) Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. Cancer Res 66:6708-6713. https://doi.org/10.1158/0008-5472.CAN-05-2732
  10. Monji M, Nakatsura T, Senju S, Yoshitake Y, Sawatsubashi M, Shinohara M, Kageshita T, Ono T, Inokuchi A, Nishimura Y (2004) Identification of a novel human cancer/testis antigen, KMHN-1, recognized by cellular and humoral immune responses. Clin Cancer Res 10:6047-6057. https://doi.org/10.1158/1078-0432.CCR-04-0475
  11. Namekawa SH, Park PJ, Zhang LF, Shima JE, McCarrey JR, Griswold MD, Lee JT (2006) Postmeiotic sex chromatin in the male germline of mice. Curr Biol 16:660-667. https://doi.org/10.1016/j.cub.2006.01.066
  12. Otu HH, Naxerova K, Ho K, Can H, Nesbitt N, Libermann TA, Karp SJ (2007) Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J Biol Chem 282:11197-11204. https://doi.org/10.1074/jbc.M608441200
  13. Park HJ, Seo HJ, Kim HW, Kim JS, Hwang SY, Seong YS (2007) The centrosomal localization of KM-HN-1 (MGC33607) depends on the leucine zipper motif and the C-terminal coiled-coil domain. Exp Mol Med 39:828-838. https://doi.org/10.1038/emm.2007.90
  14. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002) Cancer/testis antigens: An expanding family of targets for cancer immunotherapy. Immunol Rev 188:22-32. https://doi.org/10.1034/j.1600-065X.2002.18803.x
  15. Scanlan MJ, Simpson AJG, Old LJ (2004) The cancer/testis genes: Review, standardization, and commentary. Cancer Immun 4:1.
  16. Soung NK, Kang YH, Kim K, Kamijo K, Yoon H, Seong YS, Kuo YL, Miki T, Kim SR, Kuriyama R, Giam CZ, Ahn CH, Lee KS (2006) Requirement of hCenexin for proper mitotic functions of polo-like kinase 1 at the centrosomes. Mol Cell Biol 26:8316-8335. https://doi.org/10.1128/MCB.00671-06
  17. Vaughan HA, St Clair F, Scanlan MJ, Chen YT, Maraskovsky E, Sizeland A, Old LJ, Cebon J (2004) The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning. Cancer Immun 4:5.